Full-Year Revenue: In line with guidance. Second Half Profitability: Increased by 30% compared to the same period in the prior year. Underlying Operating Profit: Increased by 10% on a full-year basis. Margins: Improved into the 5% to 6% target range, with a 60 basis point improvement. Free Cash Flow: GBP150 million in the second half. Order Intake: GBP4.9 billion for the year, with a book-to-bill ratio of 102%. Net Debt: GBP100 million, with leverage at 0.3 times EBITDA. Dividend: Full-year dividend of 4.16p per share, a 22% increase from the previous year. Organic Revenue Growth: Minus 3% for the full year, flat in the second half. Operating Profit Margin: Improved by 60 basis points in 2024. North America Organic Revenue: Up 1% for the full year, with a 5% increase in the second half. UK and Europe Operating Profit: Increased by 22% to GBP148 million in 2024. UK and Europe Margin: Improved by 280 basis points since 2022, reaching 6% in 2024. Asia Pacific Organic Revenue Growth: 6% in the second half of the year. Middle East Revenue: Down 3% on a constant currency basis. Cash Conversion: Over 100% of trading profit converted to cash on average over the last five years. Capital Allocation: GBP140 million share buyback completed in 2024. Guidance for 2025: Revenue similar to 2024, with underlying organic growth of 7% offsetting reductions. Warning! GuruFocus has detected 5 Warning Signs with OCDDY. Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Serco Group PLC (SCGPY) achieved a 30% increase in second-half profitability compared to the same period in the prior year. The company delivered a meaningful improvement in margins, reaching the 5% to 6% target range. Serco Group PLC (SCGPY) reported a strong cash close for the year, enabling delivery on all elements of its capital allocation framework. The company maintained a high customer retention rate of over 95% in its two largest geographies. Serco Group PLC (SCGPY) entered 2025 with a robust pipeline of new business opportunities, including a decade-high pipeline of good quality opportunities. Negative Points Organic revenue growth for the full year was negative, with a 3% decline, although it was flat in the second half. The company faced a disappointing outcome with the Australian immigration rebate, impacting its order intake. Serco Group PLC (SCGPY) booked a non-cash exceptional permanent charge of GBP150 million against the Asia Pacific goodwill asset. The UK Armed Forces recruitment contract will not start until 2027, delaying potential revenue from this contract. The company faces cost pressures, including the increase in UK National Insurance, which may impact future profitability. Story Continues Q & A Highlights Q: Can you discuss the acquisition pipeline and the potential for expanding into new sectors in North America? A: Nigel Crossley, CFO, stated that while the balance sheet is strong, the company remains disciplined in its acquisition strategy, focusing on strategic fit and financial returns. They are exploring opportunities in non-defense markets in North America, including federal civilian business and potentially immigration, aligning with ethical standards. Q: How is the UK Armed Forces recruitment contract structured, and what are the implications of political changes in Germany on your immigration services? A: Anthony Kirby, CEO of Serco UK and Europe, explained that the UK Armed Forces recruitment contract is now a tri-service agreement, aiming for more efficient recruitment. Regarding Germany, the political situation is still evolving, but Serco is prepared to adapt to policy changes and expand its defense capabilities. Q: What are the potential impacts of the US Department of Government Efficiency (DOGE) initiative on Serco? A: Mark Irwin, CEO, noted that while DOGE creates uncertainty, it focuses on efficiency, waste reduction, and competition, areas where Serco can contribute positively. The company sees opportunities to be part of the solution for government efficiency. Q: With UK margins at 6%, how do you foresee the impact of national insurance increases, and what is the outlook for the APAC region? A: Anthony Kirby mentioned that while there are pressures from national insurance increases, contract renegotiations will eventually incorporate these costs. In APAC, the focus is on rebuilding the pipeline, with opportunities in defense and infrastructure. Q: What is the status of the Australian business in terms of cost reductions and pipeline development? A: Nigel Crossley highlighted progress in reducing overheads and improving contract performance in Australia. The pipeline includes significant base services contracts, with decisions expected mid-year, and efforts are ongoing to rebuild the business to previous levels. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Serco Group PLC (SCGPY) Full-Year 2024 Earnings Call Highlights: Strong Profitability and ...
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...